Skip to content
Home/Companies/Biotech/Aros Applied Biotechnology

Aros Applied Biotechnology

Biotech·Denmark·Exited 2013·Held 13yr
Entry
2000
Hold
13yr
Exit
2013

Who owns Aros Applied Biotechnology?

Aros Applied Biotechnology was owned by Capnova through CAPNOVA (1998 vintage) from 2000 to 2013, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-19

Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2013

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to
SynAct Pharma
Exited 2016
BiotechDenmark· 2012
SYBO Games
Exited 2012
GamingDenmark· 2011
Action Pharma
Exited 2012
BiotechDenmark· 2002
to
MediConnect
Exited 2005
HealthTechDenmark· 2001
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Aros Applied Biotechnology

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Aros Applied Biotechnology?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Aros Applied Biotechnology.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue